Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 7.00
High: 7.00
Low: 7.00
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Oct 2008 14:45

RNS Number : 4996F
Phytopharm PLC
09 October 2008
 



Phytopharm plc

9 October 2008

DIRECTOR/PDMR SHAREHOLDING - Purchase of Ordinary Shares (the "Shares") in Phytopharm plc (the "Company") by Directors of the Company under its employee Share Incentive Plan (the "SIP").

The SIP trustee, Equiniti Share Plan Trustees Limited (the "Trustee"), notified the Company on 8 October 2008 that the following Directors of the Company acquired Shares under the SIP on 7 October 2008, in each case, held by the Trustee:

Director

Number of shares acquired*

Aggregate number of Shares held beneficially following acquisition (across all accounts)

Daryl Rees

1,820

133,583

Piers Morgan

1,820

133,583

\* The number of Shares acquired includes 910 Partnership Shares purchased by each of these Directors at 13.75 pence and 910 Matching Shares issued to each of these Directors. Both partnership and matching elements are registered in the name of the Trustee.

The SIP operates as follows:

Each month the Trustee uses participants' contributions (which may not exceed £125 per participant per month) to purchase shares in the market. These shares are called "Partnership Shares".

At the same time the Company issues to participants via the Trustee one "Matching Share" for every Partnership Share purchased that month. These Matching Shares are purchased in the market and will vest with the employee three years from the date of purchase.

For further information, please contact:

Zoe McGowanHead of Finance

Phytopharm plc Tel No: +44 (0)1480 437697

Further information about Phytopharm can be found on the Company's website www.phytopharm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMLBJTMMJMBJP
Date   Source Headline
11th May 20057:01 amRNSInterim Results
10th May 20057:00 amRNSHolding(s) in Company
4th May 200511:00 amRNSOpen Offer Take Up
29th Apr 20052:39 pmRNSBlocklisting Interim Review
20th Apr 200512:06 pmRNSHolding(s) in Company
19th Apr 20054:04 pmRNSNotice of Results
8th Apr 20057:01 amRNSPlacing and Open Offer
29th Mar 20059:30 amRNSRe Agreement
21st Mar 200510:56 amRNSBlocklisting Interim Review
8th Mar 20057:01 amRNSHolding(s) in Company
8th Mar 20057:00 amRNSHolding(s) in Company
1st Mar 20052:57 pmRNSHolding(s) in Company
28th Feb 20057:03 amRNSRe Agreement
25th Feb 20051:21 pmRNSEGM Statement
24th Feb 20053:32 pmRNSResults Placing & Open Offer
2nd Feb 20057:01 amRNSOpen Offer
26th Jan 200512:22 pmRNSStmnt re Share Price Movement
20th Jan 20057:01 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.